Advances in WNK signaling of salt and potassium metabolism: Clinical implications

American Journal of Nephrology

Volumn 35, Issue 4, 2012, Pages 379-386

  Arroyo, Juan Pablo ^a,b   Gamba, Gerardo ^a,b,c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c Medicina del Dolor y Paliativa   (Mexico)

Author keywords

Angiotensin II; Electrolytes; Hypertension; Potassium; Sodium

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; PHOSPHOTRANSFERASE; POTASSIUM; PROTEIN KINASE WNK1; PROTEIN KINASE WNK3; PROTEIN KINASE WNK4; PROTEIN SERINE THREONINE KINASE; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

BLOOD PRESSURE; CONGESTIVE HEART FAILURE; ELECTROLYTE DISTURBANCE; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; NEPHRON; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; POTASSIUM BALANCE; POTASSIUM METABOLISM; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SODIUM BALANCE;

EID: 84859642327     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000337479     Document Type: Review

References (58)

1. Hoorn EJ, Nelson, JH, McCormick, JA, Ellison, DH: The WNK Kinase Network Regulating Sodium, Potassium, and Blood Pressure. J Am Soc Nephrol 2011; 22: 605-614.
2. McCormick JA, Ellison DH: The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev 2011; 91: 177-219.
3. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP: Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112. (Pubitemid 32758085)
4. Mayan H, Vered I, Mouallem M, Tzadok- Witkon M, Pauzner R, Farfel Z: Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocrinol Metab 2002; 87: 3248-3254. (Pubitemid 34816373)
5. Gordon RD, Hodsman GP: The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diuretic. Scott Med J 1986; 31: 43-44. (Pubitemid 16131291)
6. + -Cl - cotransporter: molecular biology, functional properties, and regulation by WNKs. Am J Physiol Renal Physiol 2009; 297:F838-F848.
7. Simon DB, Nelson-Williams C, Johnson-Bia M, Ellison D, Karet FE, Morey-Molina A, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996; 12: 24-30. (Pubitemid 26011315)
8. Plotkin MD, Kaplan MR, Verlander JM, Lee W-S, Brown D, Poch E, Gullans SR, Hebert SC: Localization of the thiazide sensitive Na- Cl cotransporter, rTSC1, in the rat kidney. Kidney Int 1996; 50: 174-183. (Pubitemid 26323711)
9. 2+ handling in a mouse model for Gitelman's syndrome. J Am Soc Nephrol 2004; 15: 2276-2288. (Pubitemid 39159328)
10. Bachmann S, Velázquez H, Obermuller N, Reily RF, Moser D, Ellison DH: Expression of the thiazide-sensitive Na-Cl cotransporter by rabbit distal convoluted tubule cells. J Clin invest 1995; 96: 2510-2514.
11. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP: Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wildtype but not mutant WNK4. Proc Natl Acad Sci USA 2003; 100: 680-684. (Pubitemid 36126112)
12. Arroyo JP, Ronzaud C, Lagnaz D, Staub O, Gamba G: Aldosterone paradox: differential regulation of ion transport in distal nephron. Physiology (Bethesda) 2011; 26: 115-123.
13. Reilly RF, Ellison DH: Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 2000; 80: 277-313. (Pubitemid 30060566)
14. Loffing J, Loffing-Cueni D, Valderrabano V, Klausli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B: Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 2001; 281:F1021-F1027.
15. Biner HL, Arpin-Bott MP, Loffing J, Wang X, Knepper M, Hebert SC, Kaissling B: Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 2002; 13: 836-847. (Pubitemid 34274079)
16. Ellison DH, Velazquez H, Wright FS: Thiazide- sensitive sodium chloride cotransport in early distal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 1987; 253:F546-F554.
17. Loffing J, Kaissling B: Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol 2003; 284:F628-F643. (Pubitemid 36336969)
18. Amorim JB, Bailey MA, Musa-Aziz R, Giebisch G, Malnic G: Role of luminal anion and pH in distal tubule potassium secretion. Am J Physiol Renal Physiol 2003; 284:F381-F388. (Pubitemid 36114701)
19. Hebert SC, Desir G, Giebisch G, Wang W: Molecular diversity and regulation of renal potassium channels. Physiol Rev 2005; 85: 319-371. (Pubitemid 40173996)
20. Grimm PR, Sansom SC: BK channels and a new form of hypertension. Kidney Int 2010; 78: 956-962.
21. O'Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, Kenyon CJ, Brown RW: Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006; 17: 2402-2413. (Pubitemid 44300956)
22. Bachmann S, Bostanjoglo M, Schmitt R, Ellison DH: Sodium transport-related proteins in the mammalian distal nephron - distribution, ontogeny and functional aspects. Anat Embryol (Berl) 1999; 200: 447-468. (Pubitemid 29467309)
23. Piechotta K, Lu J, Delpire E: Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alaninerich kinase (SPAK) and oxidative stress response 1 (OSR1). J Biol Chem 2002; 277: 50812-50819. (Pubitemid 36042246)
24. Vitari AC, Deak M, Morrice NA, Alessi DR: The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome, phosphorylate and active SPAK and OSR1 protein kinases. Biochem J 2005; 391: 17-24. (Pubitemid 41445471)
25. Rafiqi FH, Zuber AM, Glover M, Richardson C, Fleming S, Jovanovic S, Jovanovic A, O'Shaughnessy KM, Alessi DR: Role of the WNK-activated SPAK kinase in regulating blood pressure. EMBO Mol Med 2010; 2: 63-75.
26. Frindt G, Palmer LG: Effects of dietary K on cell-surface expression of renal ion channels and transporters. Am J Physiol Renal Physiol 2010; 299:F890-F897.
27. + secretion in the cortical collecting duct is mediated by a maxi-K channel. Am J Physiol Renal Physiol 2001; 280:F786-F793.
28. Krishna GG, Shulman MD, Narins RG: Clinical use of the potassium-sparing diuretics. Semin Nephrol 1988; 8: 354-364.
29. Rose BD: Diuretics. Kidney Int 1991; 39: 336-352.
30. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
31. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
32. Huang CL, Kuo E: Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 2007; 3: 623-630. (Pubitemid 350012824)
33. + by the rat cortical collecting duct. Am J Physiol Renal Physiol 2011; 301:F14-F20.
34. + secretion. Nat Genet 2003; 35: 372-376. (Pubitemid 37486922)
35. + channel in vitro and in vivo. Proc Natl Acad Sci USA 2007; 104: 4020-4024. (Pubitemid 47181571)
36. San Cristobal P, De Los HP, Ponce-Coria J, Moreno E, Gamba G: WNK kinases, renal ion transport and hypertension. Am J Nephrol 2008; 28: 860-870.
37. Sandberg MB, Riquier AD, Pihakaski- Maunsbach K, McDonough AA, Maunsbach AB: Angiotensin II provokes acute trafficking of distal tubule NaCl cotransporter (NCC) to apical membrane. Am J Physiol Renal Physiol 2007; 293:F662-F669. (Pubitemid 47403333)
38. van der LN, Lim CH, Fenton RA, Meima ME, Jan Danser AH, Zietse R, Hoorn EJ: Angiotensin II induces phosphorylation of the thiazide- sensitive sodium chloride cotransporter independent of aldosterone. Kidney Int 2011; 79: 66-76.
39. Zhao D, Seth DM, Navar LG: Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension 2009; 54: 120-126.
40. San Cristobal P, Pacheco-Alvarez D, Richardson C, Ring AM, Vazquez N, Rafiqi FH, Chari D, Kahle KT, Leng Q, Bobadilla NA, Hebert SC, Alessi DR, Lifton RP, Gamba G: Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway. Proc Natl Acad Sci USA 2009; 106: 4384-4389.
41. Yue P, Sun P, Lin DH, Pan C, Xing W, Wang W: Angiotensin II diminishes the effect of SGK1 on the WNK4-mediated inhibition of ROMK1 channels. Kidney Int 2011; 79: 423-431.
42. Cheng CJ, Huang CL: Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. J Am Soc Nephrol 2011; 22: 460-471.
43. He G, Wang HR, Huang SK, Huang CL: Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 2007; 117: 1078-1087. (Pubitemid 46556764)
44. Huang CL, Yang SS, Lin SH: Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 2008; 17: 519-525.
45. Lazrak A, Liu Z, Huang CL: Antagonistic regulation of ROMK by long and kidneyspecific WNK1 isoforms. Proc Natl Acad Sci USA 2006; 103: 1615-1620. (Pubitemid 43191213)
46. + homeostasis by kidney- specific WNK1 kinase. J Biol Chem 2009; 284: 12198-12206.
47. Subramanya AR, Yang CL, Zhu X, Ellison DH: Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform. Am J Physiol Renal Physiol 2006; 290:F619-F624. (Pubitemid 43724963)
48. Liu Z, Xie J, Wu T, Truong T, Auchus RJ, Huang CL: Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum Mol Genet 2011; 20: 855-866.
49. Rinehart J, Kahle KT, De Los HP, Vazquez N, Meade P, Wilson FH, Hebert SC, Gimenez I, Gamba G, Lifton RP: WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl cotransporters required for normal blood pressure homeostasis. Proc Natl Acad Sci USA 2005; 102: 16777-16782. (Pubitemid 41688853)
50. + channel ROMK1 (Kir1.1). J Physiol 2006; 571: 275-286.
51. Yang CL, Zhu X, Ellison DH: The thiazidesensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007; 117: 3403-3411. (Pubitemid 350096996)
52. Abriel H, Staub O: Ubiquitylation of ion channels. Physiology (Bethesda) 2005; 20: 398-407. (Pubitemid 41812423)
53. + homeostasis. Proc Natl Acad Sci USA 2007; 104: 4025-4029. (Pubitemid 47181572)
54. Kim G-H, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA: The thiazide-sensitive Na-Cl cotransporter is an aldosteroneinduced protein. Proc Natl Acad Sci USA 1998; 95: 14552-14557. (Pubitemid 28549405)
55. + - Cl - cotransporter via the aldosterone- SGK1-Nedd4-2 pathway. J Am Soc Nephrol 2011;22:1707-1719.
56. Bostanjoglo M, Reeves WB, Reilly RF, Velazquez H, Robertson N, Litwack G, Morsing P, Dorup J, Bachmann S, Ellison DH, Bostonjoglo M: 11Beta- hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J Am Soc Nephrol 1998; 9: 1347-1358. (Pubitemid 28354544)
57. Wang XY, Masilamani S, Nielsen J, Kwon TH, Brooks HL, Nielsen S, Knepper MA: The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. J Clin Invest 2001; 108: 215-222. (Pubitemid 32656245)
58. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williamns C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP: Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407-414. (Pubitemid 24346056)